The spectrum of acute bronchitis

References

• MacKay DN. Treatment of acute bronchitis in adults without underlying lung disease. J Gen Intern Med 1996; 11(9):557–62
   PubMed Web of Science ®Google Scholar
• Rodnick JE, Gude JK. The use of antibiotics in acute bronchitis and acute exacerbations of chronic bronchitis. West J Med 1988; 149(3):347–51
   PubMedGoogle Scholar
• Jonsson JS, Sigurdsson JA, Kristinsson KG, et al. Acute bronchitis in adults: how close do we come to its aetiology in general practice? Scand J Prim Health Care 1997; 15(3): 156–60
   PubMed Web of Science ®Google Scholar
• Dere WH. Acute bronchitis: results of US and European trials of antibiotic therapy. Am J Med 1992; 92(6A):53–7S
   Google Scholar
• Sethi S. Infectious exacerbations of chronic bronchitis: diagnosis and management. J Antimicrob Chemother 1999; 43 (Suppl A):97–105
   PubMedGoogle Scholar
• Miravitlles M, Espinosa C, Fernandez-Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999; 116(1):40–6
   PubMed Web of Science ®Google Scholar
• Eller J, Ede A, Schaberg T, et al. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 1998; 113(6): 1542–8
   PubMed Web of Science ®Google Scholar
• Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995; 108(2 Suppl):43–52S
   Google Scholar
• Mogulkoc N, Karakurt S, Isalska B, et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med 1999; 160(1):349–53
   Google Scholar
• Gwaltney JM Jr. Acute bronchitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000: 703–6
   Google Scholar
• Macfarlane JT, Colville A, Guion A, et al. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 1993; 341 (8844):511–4
   Google Scholar
• Chodosh S, Schreurs A, Siami G, et al. Efficacy of oral ciprofloxacin vs clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Clin Infect Dis 1998; 27(4):730–8
   PubMed Web of Science ®Google Scholar
• Anzueto A, Niederman MS, Tillotson GS, et al. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg bid versus clarithromycin 500 mg bid. Bronchitis Study Group. Clin Ther 1998; 20(5):885–90
   Google Scholar
• Kaiser L, Lew D, Hirschel B, et al. Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996; 347(9014): 1507–10
   Google Scholar
• Falck G, Heyman L, Gnarpe J, et al. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scand J Infect Dis 1994; 26(2):179–87
   PubMed Web of Science ®Google Scholar
• Buscho RO, Saxtan D, Shultz PS, et al. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 1978; 137(4):377–83
   PubMed Web of Science ®Google Scholar
• Smith CB, Golden CA, Kanner RE, et al. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 1980; 121 (2):225–32
   PubMed Web of Science ®Google Scholar
• Herwaldt LA. Pertussis in adults: what physicians need to know. Arch Intern Med 1991; 151(8):1510–2
   Google Scholar
• Falsey AR, McCann RM, Hall WJ, et al. The “common cold” in frail older persons: impact of rhinovirus and Coronavirus in a senior daycare center. J Am Geriatr Soc 1997; 45(6):706–11
   Google Scholar
• Boldy DA, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med 1990; 84(5):377–85
   Google Scholar
• Hendley JO, Fishburne HB, Gwaltney JM Jr. Coronavirus infections in working adults: eight-year study with 229 E and OC 43. Am Rev Respir Dis 1972; 105(5):805–11
   PubMedGoogle Scholar
• Greenberg SB, Allen M, Wilson J, et al. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162(1): 167–73
   Google Scholar
• Monso E, Ruiz J, Roseli A, et al. Bacterial infection in chronic obstructive pulmonary disease: a study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152(4 Pt 1):1316–20
   PubMed Web of Science ®Google Scholar
• Fagon JY, Chastre J, Trouillet JL, et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis: use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990; 142(5): 1004–8
   PubMed Web of Science ®Google Scholar
• Cabello H, Torres A, Celis R, et al. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J 1997; 10(5):1137–44
   PubMed Web of Science ®Google Scholar
• Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157(5 Pt 1):1498–505
   PubMed Web of Science ®Google Scholar
• Hueston WJ, Mainous AG 3d, Dacus EN, et al. Does acute bronchitis really exist? A reconceptualization of acute viral respiratory infections. J Fam Pract 2000; 49(5):401–6
   Google Scholar
• Reimer LG, Carroll KC. Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections. Clin Infect Dis 1998; 26(3):742–8
   PubMed Web of Science ®Google Scholar
• Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997; 278(11):901–4
   PubMed Web of Science ®Google Scholar
• Fahey T, Stocks N, Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ 1998; 316(7135):906–10
   PubMedGoogle Scholar
• Smucny JJ, Becker LA, Glazier RH, et al. Are antibiotics effective treatment for acute bronchitis? A meta-analysis. J Fam Pract 1998; 47(6):453–60
   Google Scholar
• Bent S, Saint S, Vittinghoff E, et al. Antibiotics in acute bronchitis: a meta-analysis. Am J Med 1999; 107(1):62–7
   Google Scholar
• Saint S, Bent S, Vittinghoff E, et al. Antibiotics in chronic obstructive pulmonary disease exacerbations: a metaanalysis. JAMA 1995:273(12):957–60
   Google Scholar
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995; 152(5 Pt 2): S77–121
   PubMed Web of Science ®Google Scholar
• Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146(4):1067–83
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106(2):196–204
   PubMed Web of Science ®Google Scholar
• Adams SG, Melo J, Luther M, et al. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest 2000; 117(5): 1345–52
   PubMed Web of Science ®Google Scholar
• Niroumand M, Grossman RF. Airway infection. Infect Dis Clin North Am 1998; 12(3):671–88
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(5 Pt 1):1418–22
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161 (5): 1608–13
   PubMed Web of Science ®Google Scholar
• Ball P, Harris JM, Lowson D, et al. Acute infective exacerbations of chronic bronchitis. QJM 1995; 88(1):61–8
   PubMed Web of Science ®Google Scholar
• Sethi S. Etiology and management of infection in chronic obstructive pulmonary disease. Clin Pulm Med 1999; 6:327–32
   Google Scholar
• Niederman MS, McCombs JS, Unger AN, et al: Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther 1999; 21(3):576–91
   PubMed Web of Science ®Google Scholar
• Shah PM, Maesen FP, Dolmann A, et al. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. J Antimicrob Chemother 1999; 43(4):529–39
   PubMed Web of Science ®Google Scholar
• Wilson R, Kubin R, Ballin I, et al. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1999; 44(4):501–13
   PubMed Web of Science ®Google Scholar
• Lode H. Respiratory tract infections: when is antibiotic therapy indicated? Clin Ther 1991; 13(1): 149–56
   Google Scholar
• Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract 1994; 39(5):437–40
   Google Scholar
• Grossman RF. Guidelines for the treatment of acute exacerbations of chronic bronchitis. Chest 1997; 112(6 Suppl):310–3S
   Google Scholar
• Wilson R. Outcome predictors in bronchitis. Chest 1995; 108(2 Suppl):53–7S
   Google Scholar
• Grossman R, Mukherjee J, Vaughan D, et al. A 1 -year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis. The Canadian Ciprofloxacin Health Economic Study Group. Chest 1998; 113(1):131–41
   Google Scholar
• Destache CJ, Dewan N, O'Donohue WJ, et al. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 1999; 43(Suppl A):107–13
   Google Scholar
• Guillemot D. Antibiotic use in humans and bacterial resistance. Curr Opin Microbiol 1999; 2(5):494–8
   Google Scholar
• Thornsberry C, Ogilvie PT, Holley HP Jr, et al. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective US study. Antimicrob Agents Chemother 1999; 43(11):2612–23
   Google Scholar
• Blondeau JM. A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new 'respiratory quinolones.' J Antimicrob Chemother 1999; 43(Suppl B):1–11
   Web of Science ®Google Scholar
• Thomson KS, Chartrand SA, Sanders CC, et al. In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance. J Antimicrob Chemother 1999; 43(Suppl C):15–9
   Google Scholar
• Chen DK, McGeer A, de Azavedo JC, et al. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999; 341(4):233–9
   PubMed Web of Science ®Google Scholar
• Doern GV, Jones RN, Pfaller MA, et al. Haemophilus influenzae and Moraxella catarrhalis from patients with community- acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother 1999; 43(2):385–9
   Google Scholar
• Doern GV, Pfaller MA, Kugler K, et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998; 27(4):764–70
   PubMed Web of Science ®Google Scholar
• Gotfried MH. Comparison of bacteriologie eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance. Clin Ther 2000; 22(1):2–14
   Google Scholar